Clinical Trials Directory

Trials / Completed

CompletedNCT01346709

Prospective Evaluation of a RIsk Score for Postoperative Pulmonary COmPlications in Europe

Prospective Evaluation of a RIsk Score for Postoperative Pulmonary COmPlications in Europe: Predicting Postoperative Pulmonary Complications in Europe: a 7-day Data Collection, Prospective, Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
5,450 (actual)
Sponsor
European Society of Anaesthesiology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective Evaluation of a RIsk Score for postoperative pulmonary COmPlications in Europe (PERISCOPE) is a multi-centre, international observational study of a random-sample cohort of patients undergoing a nonobstetric in-hospital surgical procedure under general or regional anaesthesia during a continued 7-day period of recruitment.

Detailed description

Prospective Evaluation of a RIsk Score for postoperative pulmonary COmPlications in Europe (PERISCOPE) is a multi-centre, international observational study of a random-sample cohort of patients undergoing a nonobstetric in-hospital surgical procedure under general or regional anaesthesia during a continued 7-day period of recruitment. Participating centres throughout Europe will contribute routine clinical data describing all eligible patients who undergo surgery during a continuous week (7-days) at convenience of every department within a period of two months from May 1st to July 1st 2011. A questionnaire of around 50 items will be filled during the pre, intra and postoperative periods. The follow-up will end at discharge. The aim of the PERISCOPE study is to validate a simple score to predict postoperative pulmonary complications(PPCs). This score has recently been published in Anesthesiology and you can access linking to: http://journals.lww.com/anesthesiology/Fulltext/2010/12000/Prediction\_of\_Postoperative\_Pulmonary.20.aspx TIMEFRAME Participants will be followed for the duration of in-hospital stay, an expected average of maximum 5 weeks.

Conditions

Timeline

Start date
2011-05-01
Primary completion
2011-08-01
Completion
2011-09-01
First posted
2011-05-03
Last updated
2022-04-05
Results posted
2022-04-05

Locations

63 sites across 21 countries: Albania, Belgium, Bosnia and Herzegovina, Croatia, Czechia, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Luxembourg, Poland, Portugal, Romania, Russia, Spain, Switzerland, Turkey (Türkiye), Ukraine

Source: ClinicalTrials.gov record NCT01346709. Inclusion in this directory is not an endorsement.